Background

The aims of our study were to evaluate the complications and long-term outcomes of PCI with implantations of long biolimus A9-eluting stents in proximal anterior descending artery (LAD).

Methods

We included in the study 209 patients within the period of January 2006–December 2007. All patients had long lesions in proximal LAD and underwent PCI in Sani Konukoglu Medical Center, Gaziantep, Turkey. BioMatrix stents (Biosensors International, Switzerland), which elute Biolimus A9, were implanted in all cases. Clinical follow-up was conducted at 1, 6 and 12 months to collect data on BioMatrix-related MACE (death, MI and TVR).

Methods

We included in the study 209 patients within the period of January 2006–December 2007. All patients had long lesions in proximal LAD and underwent PCI in Sani Konukoglu Medical Center, Gaziantep, Turkey. BioMatrix stents (Biosensors International, Switzerland), which elute Biolimus A9, were implanted in all cases. Clinical follow-up was conducted at 1, 6 and 12 months to collect data on BioMatrix-related MACE (death, MI and TVR).

Only gold members can continue reading. Log In or Register to continue

Share this:

• Click to share on Twitter (Opens in new window)
• Click to share on Facebook (Opens in new window)

Related

Related posts:

1. Coronary stenting with MGuard: extended follow-up of first human trial
2. Understanding the impact of drug-eluting stent on vascular function and the nitric oxide pathway genes using a pig coronary artery stent implantation model
3. Treatment of STEMI with neither PCI nor thrombolysis
4. Definite stent thrombosis: a 2-center New Zealand registry

Stay updated, free articles. Join our Telegram channel

Join

Full access? Get Clinical Tree